PO-2242 HDR-brachytherapy increases PD-L-1 immune expression on prostate cancer (NCT04247217)
Vanneste, B., Van Limbergen, E., Dubois, L., Wieten, L., Aarts, M., Van Roermund, J., Marcelissen, T., Li, X., Samarasks, I., De Ruysscher, D.
Published in Radiotherapy and oncology (01.05.2023)
Published in Radiotherapy and oncology (01.05.2023)
Get full text
Journal Article